Slide1 l.jpg
This presentation is the property of its rightful owner.
Sponsored Links
1 / 40

Kevin Latinis, M.D./Ph.D. Division of Rheumatology Dept. of Internal Medicine [email protected] PowerPoint PPT Presentation


  • 89 Views
  • Uploaded on
  • Presentation posted in: General

Rheumatology 101: What you need to know for your ambulatory medicine experience. Kevin Latinis, M.D./Ph.D. Division of Rheumatology Dept. of Internal Medicine [email protected] Rheumatology 101. Arthritis -Inflammatory (RA, spondyloarthropathies) -Mechanical (OA) Lupus Fibromyalgia

Download Presentation

Kevin Latinis, M.D./Ph.D. Division of Rheumatology Dept. of Internal Medicine [email protected]

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Slide1 l.jpg

Rheumatology 101:What you need to know for your ambulatory medicine experience

Kevin Latinis, M.D./Ph.D.

Division of Rheumatology

Dept. of Internal Medicine

[email protected]


Rheumatology 101 l.jpg

Rheumatology 101

  • Arthritis-Inflammatory (RA, spondyloarthropathies)-Mechanical (OA)

  • Lupus

  • Fibromyalgia

  • Low back pain and other peri-articular complaints

  • General musculoskeletal exam (time permitting)


Mechanical vs inflammatory arthritis l.jpg

Mechanical vs. Inflammatory Arthritis

Latinis, K., et al TheWashington Manual Rheumatology Subspecialty Consult., LWW, 2003.


Osteoarthritis background l.jpg

Osteoarthritis-Background

  • Very common-2nd leading cause for disability in USA-In patients 60 and older: affects 17% of men and 30% of women-Estimated that 59.4 million patients will have OA by the year 2020

  • Etiology-primary idiopathic-secondary


Osteoarthritis distribution l.jpg

Osteoarthritis-Distribution

Bouchard’s

Heberden’s

Latinis, K., Dao, K, Shepherd, R, Gutierrez, E, Velazquez, C. TheWashington Manual Rheumatology Subspecialty Consult., LWW, 2003.


Osteoarthritis diagnosis l.jpg

Osteoarthritis-Diagnosis

  • Clinical

  • Supported by X-rays

  • Non-inflammatory lab data, if any


Osteoarthritis treatment l.jpg

Osteoarthritis-Treatment

  • Pain relief-Analgesics and NSAIDs/Cox-2 Inhibitors

  • SMOADs (structure modifying osteoarthritis drugs)-Glucosamine Sulfate -see meta-analysis McAlindon et al. JAMA, 283: 3/2000, p. 1469-many under development

  • Non-pharmacologic approaches-Reduce stress/load on joint-Strengthen surrounding muscles-PT/OT-Weight reduction-Patient education

  • Limit disability and improve quality of life


Osteoarthritis treatment9 l.jpg

Osteoarthritis-Treatment

  • Joint Replacement Surgery-Primarily of knee and hip, but also available in hands, shoulders,& elbows-Indications:1. pain at rest2. instability-patients benefit from aggressive PT before & after surgery

  • Other surgical procedures


Clinical pearl arthritis of the dip joint l.jpg

Clinical Pearl:Arthritis of the DIP joint

Psoriatic Arthritis (inflammatory)

OA (non-inflammatory)


Inflammatory arthritis l.jpg

Inflammatory Arthritis

  • Rheumatoid arthritis

  • Spondyloarthropathies-Undifferentiated-Ankylosing spondylitis-Psoriatic arthritis-Reactive arthritis (formerly Reiter’s syndrome)-Enteropathic arthritis

  • SLE, Sjogrens, Scleroderma, Polymyalgia rheumatica, Vasculitis, Infectious (bacterial, viral, other), Undifferentiated connective tissue disease


Slide12 l.jpg

Latinis, K., et al TheWashington Manual Rheumatology Subspecialty Consult., LWW, 2003.


Rheumatoid arthritis background l.jpg

Rheumatoid Arthritis-Background

  • Symmetric, inflammatory polyarthritis

  • Affects ~1% of our population

  • Occurs in women 3x more than men

  • Etiology-Genetic, class II molecules (HLA-DRB1)-Autoimmune-?Environmental


Rheumatoid arthritis distribution l.jpg

Rheumatoid Arthritis-Distribution

Latinis, K., et alTheWashington Manual Rheumatology Subspecialty Consult., LWW, 2003.


Slide15 l.jpg

Latinis, K., et al TheWashington Manual Rheumatology Subspecialty Consult., LWW, 2003.


Systemic lupus erythematosus lupus background l.jpg

Systemic Lupus Erythematosus (Lupus)-Background

Definition

-An inflammatory multisystem disease of unknown etiology

with protean clinical and laboratory manifestations and a

variable course and prognosis.

-Immunologic aberrations give rise to excessive autoantibody

production, some of which cause cytotoxic damage, while

others participate in immune complex formation resulting in

immune inflammation.


Systemic lupus erythematosus lupus background17 l.jpg

Systemic Lupus Erythematosus (Lupus)-Background

Clinical features

-Clinical manifestations may be constitutional or result from

inflammation in various organ systems including skin and

mucous membranes, joints, kidney, brain, serous membranes,

lung, heart and occasionally gastrointestinal tract.

-Organ systems may be involved singly or in any combination.

-Involvement of vital organs, particularly the kidneys and

central nervous system, accounts for significant morbidity

and mortality.

-Morbidity and mortality result from tissue damage due to

the disease process or its therapy.


Systemic lupus erythematosus classification criteria soap brain md l.jpg

1. Serositis: (a) pleuritis, or (b) pericarditis

2. Oral ulcers

3. Arthritis

4. Photosensitivity

10. Malar rash

11. Discoid rash

5. Blood/Hematologic disorder: (a) hemolytic anemia or(b) leukopenia of < 4.0 x 109(c) lymphopenia of < 1.5 x 109(d) thrombocytopenia < 100 X 109

6. Renal disorder: (a) proteinuria > 0.5 gm/24 h or 3+ dipstick or(b) cellular casts

7. Antinuclear antibody (positive ANA)

8. Immunologic disorders: (a) raised anti-native DNA antibody binding or(b) anti-Sm antibody or (c) positive anti-phospholipid antibody work-up

9. Neurological disorder: (a) seizures or (b) psychosis

Systemic lupus erythematosus classification criteria(SOAP BRAIN MD)

". ..A person shall be said to have SLE if four or more of the 11 criteria are present, serially or simultaneously, during any interval of observation."


Slide19 l.jpg

53 yo BF with severe generalized weakness,

weight loss, and chronic psychosis

Alopecia

Psychosis

Malar rash

Arthritis


Laboratory data l.jpg

Laboratory Data

139

106

16

7.7

101

298

3.9

4.3

21

1.4

22.3

MCV=83

24 hour urine

Protein=514

Absolute lymph=0.5

ESR=119

CH50=67 (118-226)

C3=31 (83-185)

C4=18 (12-54)

ANA + 1:5280

Anti DNA +

Direct & Indirect Coombs +

Anti-IgG +


Treatment of sle l.jpg

Arthritis, arthralgias, myalgias:NSAIDS, anti-malarials (eg. Plaquenil), Steroids-injections, oral methotrexate

Photosensitivity, dermatitisavoid Sun exposuretopical steroidsPlaquenil

Weight loss and fatiguesteroids

Abortion, fetal lossASAimmunosuppression

Thrombosisanti-coagulants

Glomerulonephritissteroidspulse cytotoxicsmycophenylate mofetil

CNS diseaseanti-coagulants for thrombosissteroids and cytotoxics for vasculitis

Infarction (secondary to vasculitis)steroidscytotoxicsprostacyclin

CytopeniassteroidsIVIG-short term for thrombocytopeniadanazolcytotoxics-if bone marrow status is known

Treatment of SLE


Steroids in lupus l.jpg

Steroid responsiveDermatitis (local)

Polyarthritis

Serositis

Vasculitis

Hematological

Glomerulonephritis (most)

Myelopathies

Steroid non-responsiveThrombosisChronic renal damageHypertensionSteroid-induced psychosisInfection

Steroids in Lupus


Ana when to order and how to follow up on a positive test l.jpg

ANA-When to order and how to follow up on a positive test

Latinis, K., et al TheWashington Manual Rheumatology Subspecialty Consult., LWW, 2003.


Slide25 l.jpg

Latinis, K., et al TheWashington Manual Rheumatology Subspecialty Consult., LWW, 2003.


Fibromyalgia background l.jpg

Fibromyalgia-Background

  • Chronic musculoskeletal pain syndrome of unknown etiology

  • Characterized by diffuse pain, tender points, fatigue, and sleep disturbances

  • Prevalence is 2-5% with a female to male predominance of 8:1

  • Mean age is 30-60


Fibromyalgia diagnosis l.jpg

Fibromyalgia-Diagnosis


Slide28 l.jpg

4

3

1

2

6

5

7

8

9


Fibromyalgia treatment l.jpg

Fibromyalgia-Treatment


Low back pain and other peri articular complaints background l.jpg

Low back pain and other peri-articular complaints-background

  • Very common, one of the most frequent reasons to visit primary care physicians

  • Articular vs peri-articular problems-Articular pain is generally deep or diffuse and worsens with active and passive motion-Periarticular pain usually exibits point tenderness and increased tenderness with active, but NOT passive motion


Slide32 l.jpg

Latinis, K., et al TheWashington Manual Rheumatology Subspecialty Consult., LWW, 2003.


Slide33 l.jpg

Latinis, K., et al TheWashington Manual Rheumatology Subspecialty Consult., LWW, 2003.


Slide34 l.jpg

Latinis, K., et al TheWashington Manual Rheumatology Subspecialty Consult., LWW, 2003.


Slide35 l.jpg

Muscles of the rotator cuff:

Supraspinatus

Infraspinatus

Subscapularis

Teres Minor


Low back pain and other peri articular complaints treatment l.jpg

Low back pain and other peri-articular complaints-Treatment

  • RICE-Rest-Ice-Compression-Elevation

  • NSAIDs and analgesics

  • Time

  • Other


General musculoskeletal exam l.jpg

General Musculoskeletal Exam

  • Underutilized by primary care providers

  • Should be simple and quick

  • Goal is to recognize signs of rheumatological diseases and determine if it is appropriate to refer to a rheumatologist or manage independently


Summary l.jpg

Summary

  • Arthritis-Inflammatory (RA, spondyloarthropathies)-Mechanical (OA)

  • Lupus

  • Fibromyalgia

  • Low back pain and other peri-articular complaints

  • General musculoskeletal exam (time permitting)


  • Login